Sr. VP & General Counsel Zangerle sold 15,000 STE shares at $265.14 (11 Nov); holdings now 33,669 shares post-transaction.
Zangerle, STERIS's Sr. VP, General Counsel, and Secretary, executed a sale of 15,000 shares at $265.14 on 2025-11-11, reducing his holdings from 48,669 shares to 33,669 shares—a reduction of 30.8% of his pre-transaction position. The sale occurred near the 52-week high ($267.99), with the stock currently trading at $260.44. STERIS is a mature-stage company with $1.5B in quarterly revenue, a 37.15 P/E, and a $25.6B market cap, indicating an established business without growth distress signals. No prior trade history, scheduled plan disclosures, or material business developments are referenced that would contextualize timing or motivation for this sale. The transaction is within bounds of normal executive portfolio activity but the magnitude (one-third of holdings) and proximity to 52-week highs merit tracking to assess whether this represents a broader insider sentiment shift at the company level.